Iscriviti per creare notifiche per gli Strumenti,
gli Eventi Economici ed i contenuti degli autori che segui
Iscriviti gratis Hai già un conto? Accedi
30,83
+0,04
+0,13%
quotazioni
Tutti i tipi di strumenti
- Tutti i tipi di strumenti
- Indici
- Azioni
- ETF
- Fondi
- Mat. prime
- Valute
- Cripto
- Obbl.
- Certificati
Per Favore, prova con una nuova ricerca
🚀 I rialzi di maggio: l'AI li ha anticipati: PRFT+55% in soli 16 giorni! I valori di giugno sono in arrivo. Vedi lista
Virtus Kar Health Sciences Fund Class A (RAGHX)
Aggiungi/Rimuovi dal Portafoglio
Aggiungere uno strumento a:
- Rating di Morningstar:
- Asset totali: 134,92M
AllianzGI Health Sciences A
30,83
+0,04
+0,13%
- Generale
- Grafici
- News e Analisi
- Sezione tecnica
- Forum
- Panoramica
- Profilo
- Dati Storici
- Holding
RAGHX Panoramica
Su questa pagina troverai un profilo dettagliato su Virtus Kar Health Sciences Fund Class A. Scopri di più su gestione, asset totali, strategie di investimento e informazioni di contatto di RAGHX, ed altre informazioni.
Informazioni di contatto
Indirizzo
Greenfield, MA, 01301
Greenfield,MA 01301
United States
Greenfield,MA 01301
United States
Telefono
+1 8002431574
Rete
www.virtus.com
Vertici Esecutivo
| Nome | Titolo | Dal | Fino a |
|---|---|---|---|
| Jon K Christensen | Portfolio Manager | 2022 | Adesso |
| Biografia | Jon Christensen, CFA, Portfolio Manager | Mr. Christensen is a Portfolio Manager and a Senior Research Analyst with primary research responsibilities for the small and mid-capitalization health-care sector. Before joining Kayne Anderson Rudnick in 2001, Mr. Christensen was a Portfolio Manager and Senior Research Analyst for Doheny Asset Management and has approximately 18 years of equity research experience. He earned a B.S. in Mathematics/Applied Science from the University of California, Los Angeles, and an M.B.A. from the California State University, Long Beach. Mr. Christensen is a Chartered Financial Analyst charterholder. | ||
| Chris Armbruster | Portfolio Manager + Senior Research Analyst | 2022 | Adesso |
| Biografia | Mr. Armbruster is a Portfolio Manager and Research Analyst at KAR with primary research responsibilities for the large-capitalization consumer discretionary, health care, and information technology sectors. Before joining Kayne Anderson Rudnick in 2013, Mr. Armbruster worked at B. Riley & Co. as an associate analyst covering special situations, and at Al Frank Asset Management as a vice president in equity research. | ||
| Christopher Chin | - | 2020 | 2022 |
| Peter Pirsch | Senior Portfolio Manager | 2018 | 2022 |
| Biografia | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| Bret Jones | Portfolio Manager | 2018 | 2019 |
| Biografia | Mr. Jones is a portfolio manager, senior analyst and a director with Allianz Global Investors, which he joined in 2018. He is a member of the Health Care team covering health care services companies.He was previously a senior health care analyst at Pura Vida Investments; Oppenheimer; Brean Murray, Carret and Leerink Swann. Before that, Mr. Jones was an equity research associate at SG Cowen. He has a B.S., magna cum laude, in finance from Florida State University, and an M.B.A. from Kelley School of Business, Indiana University. Mr. Jones is a CFA charterholder. | ||
| John R. Schroer | Portfolio Manager | 2014 | 2018 |
| Biografia | Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. He is the sector head of the Health Care team. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. in history and international relations and an M.B.A. in finance from the University of Wisconsin. | ||
| Michael Dauchot | Portfolio Manager | 2005 | 2018 |
| Biografia | Dr. Dauchot, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 1999. He is a member of the Health Care team, focusing on medical technology, life-science tools and diagnostics. He previously worked at Pequot Capital Management and BancBoston Robertson Stephens. Dr. Dauchot has a degree in chemistry from Case Western Reserve University, an M.B.A. from the Kellogg School of Management at Northwestern University and an M.D. from the University of Cincinnati College of Medicine. | ||
| Paul A. Wagner | Senior Research Analyst | 2008 | 2014 |
| Biografia | Mr. Wagner, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 2006. He has biotechnology responsibilities for the US Health Care team and has 14 years of investment-industry experience. Mr. Wagner previously worked at PDL BioPharma in corporate and business development, and was a vice president and senior equity-research analyst in the biotechnology sector at Lehman Brothers. He has a B.S. in chemistry from the University of Wisconsin and a Ph.D. in chemistry from the California Institute of Technology. | ||
| Ken H. Tsuboi | Health Care team | 2007 | 2013 |
| Biografia | Ken joined RCM in 1996, beginning his work on the Health Care team in 2000. Ken covers international healthcare companies, analyzing stocks for recommendation to the international portfolio management team. Previously, Mr. Tsuboi was an Asset Backed Analyst for RCM's fixed income team, where he was responsible for the implementation, strategy and evaluation of all asset- backed products. Prior to RCM, Ken was a Senior Portfolio Strategist at Payden & Rygel. | ||
| Dan Hunt | Member | 2008 | 2013 |
| Biografia | Dan was responsible for proprietary and client-directed investment idea generation across sectors, with an emphasis on healthcare. He was appointed (as the youngest member) to SG Cowen’s seven-person Investment Policy Committee. Prior to joining SG Cowen, Dan worked for Thomson Financial/Carson in New York as a Senior Associate within Capital Markets Intelligence. Dan holds the Chartered Financial Analyst designation. | ||
Scrivi ciò che pensi su Virtus Kar Health Sciences Fund Class A
Sei sicuro di voler cancellare questo grafico?
Cancella Annulla
Sostituire il grafico allegato con un nuovo grafico?
Sostituisci Annulla
Guida sui Commenti
Allega un Grafico ai Commenti
Conferma blocco
Sei sicuro di voler bloccare %USER_NAME%?
Confermando il blocco tu e %USER_NAME% non potrete più vedere reciprocamente i vostri post su Investing.com.
%USER_NAME% è stato aggiunto correttamente alla lista di utenti bloccati
Poiché hai appena sbloccato questa persona, devi aspettare 48 ore prima di bloccarla nuovamente.
Segnala questo commento
Considero questo commento come:
Commento contrassegnato
Grazie!
La tua segnalazione è stata inviata ai nostri moderatori che la esamineranno